IL1B and infection: As treatments with the p38 inhibitor, SB203580, and the NFκB inhibitor, curcumin, prior to infection were able to almost completely abrogate IL-1β production during GAS infection, we concluded that IL-1β is, indeed, produced in response to activation of this inflammatory pathway (Figure 2).